American Philosophical Society
Member History

Results:  2 ItemsModify Search | New Search
Page: 1Reset Page
Residency
Resident[X]
Class
Subdivision
201. Molecular Biology and Biochemistry[X]
1Name:  Dr. Louis J. Ignarro
 Institution:  University of Callifornia, Los Angeles
 Year Elected:  2007
 Class:  2. Biological Sciences
 Subdivision:  201. Molecular Biology and Biochemistry
 Residency:  Resident
 Living? :   Living
 Birth Date:  1941
   
 
Louis J. Ignarro is a Distinguished Professor of Pharmacology at the UCLA School of Medicine and winner of the 1998 Nobel Prize for Medicine for his groundbreaking discovery of the importance of nitric oxide in cardiovascular health. In addition to the Nobel Prize, Dr. Ignarro has also received numerous other special awards for his research, including the Basic Research Prize of the American Heart Association, the CIBA award for Hypertension Research, and the Roussel Uclaf Prize for Cell Communication and Signaling. He has been elected to the National Academy of Sciences and the American Academy of Arts & Sciences and has published over 500 scholarly articles in his career. For nearly 30 years Dr. Ignarro's research has focused on the role of nitric oxide in the cardiovascular system. Among the most significant contributions from Dr. Ignarro's wealth of research is the discovery that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling the vessels to expand and contract. A shortage of nitric oxide production, caused by poor diet and lack of physical activity, leads to the onset and increasing severity of cardiovascular disease, including heart attack, stroke, and high cholesterol. In addition, Dr. Ignarro's experiments in 1990 led to the discovery that nitric oxide is the neurotransmitter responsible for penile erection. The discovery made it possible to develop and market Viagra, the first oral medication for the effective treatment of erectile dysfunction. As a result of his role in this blockbuster drug, Dr. Ignarro is sometimes known as "the father of Viagra". In addition to continuing to lead an active team of researchers in his lab at UCLA, Dr. Ignarro now focuses on communicating the benefits of enhanced nitric oxide production to the general public. His goal is to wipe out heart disease using the scientific knowledge he has created. His work proves that almost all cardiovascular disease is preventable. Louis J. Ignarro was born in Brooklyn, New York in 1941, the son of uneducated Italian immigrants. He received a B.Sc. in chemistry and pharmacy from Columbia University in 1962, a Ph.D. in pharmacology from the University of Minnesota in 1966, and postdoctoral training in the Laboratory of Chemical Pharmacology at the National Institutes of Health in 1966-68.
 
2Name:  Dr. Baldomero M. Olivera
 Institution:  University of Utah
 Year Elected:  2007
 Class:  2. Biological Sciences
 Subdivision:  201. Molecular Biology and Biochemistry
 Residency:  Resident
 Living? :   Living
 Birth Date:  1941
   
 
Baldomero (Toto) Olivera was born in Manila, studied chemistry at the University of the Philippines, and received his Ph.D. from Caltech in 1966 working with Norman Davidson on the Biophysical Chemistry of DNA. As a post-doctoral fellow at Stanford University with I. R. Lehman, Olivera discovered and characterized E. coli DNA ligase, a key enzyme of replication and recombinant DNA technology. He returned to the Philippines in 1969, where he began to investigate pharmacologically-active peptides ("conotoxins") from the venoms of the predatory cone snails (Conus). Due to the unsettled political situation, he left the Philippines for the University of Utah in 1972 where he is now Distinguished Professor of Biology. There are ~100,000 different conotoxins; these have proven to be important tools for understanding ion channel and receptor function in nervous systems. Several conotoxins discovered in Olivera's lab have therapeutic applications, particularly for alleviating pain; one is an approved drug. Olivera's studies on cone snails have led to his present focus on the molecular and chemical basis of biodiversity.
 
Election Year
2007[X]